查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948992

管瓶適配器市場：按最終用戶、交付方式、分銷管道、材料和應用分類，全球預測，2026-2032年

Vial Adapter Market by End User, Delivery Mode, Distribution Channel, Material, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，管瓶轉接器市值為 8.0517 億美元，預計到 2026 年將成長至 8.296 億美元，年複合成長率為 6.91%，到 2032 年將達到 12.8547 億美元。

關鍵市場統計數據
基準年 2025 8.0517億美元
預計年份：2026年 8.296億美元
預測年份 2032 12.8547億美元
複合年成長率 (%) 6.91%

一份簡明策略概述，闡述了管瓶適配器設計、臨床效用和採購重點，旨在幫助經營團隊進行決策和製定產品策略。

管瓶適配器是藥品與給藥系統之間的關鍵介面，可在臨床和非臨床環境中安全且有效率地取得管瓶內容物。本執行摘要整合了對競爭格局、技術演進、監管互動和供應鏈趨勢的策略洞察，旨在揭示影響價值鏈各相關人員採購、設計決策和商業化策略的因素。本概要針對高階管理人員、產品負責人、採購人員和臨床營運團隊，協助他們將投資與實際實施路徑結合。

深入檢驗正在重新定義管瓶適配器產品預期和供應鏈優先事項的技術、監管和採購方面的整合變化。

管瓶適配器市場正面臨多重同步變化，這些變化正在重塑產品藍圖和商業性策略。技術成熟度的提升，包括安全設計和自動加藥介面的廣泛應用，顯著推動了先進醫療環境中此類產品的普及。同時，材料科學的進步使得輕量化、符合人體工學的組件成為可能，從而減少了醫療設備相關廢棄物，並改善了臨床和家庭環境中的操作體驗。

從分析觀點探討不斷變化的關稅趨勢對管瓶適配器相關人員的籌資策略、製造地和分銷韌性的影響

近期主要進口國的貿易措施和關稅調整對支持管瓶適配器生產和分銷的供應鏈產生了廣泛影響。關稅調整凸顯了供應鏈多元化的重要性，促使許多企業重新評估其採購、製造地和庫存策略，以降低跨境成本波動帶來的風險。為此，採購部門正在加快供應商資質審核流程，並優先考慮多種採購方案，以確保供應的連續性。

透過對終端用戶環境、產品類型、供應模式、分銷管道結構、材料選擇和臨床應用等因素進行綜合細分分析，實現策略性產品定位。

要了解市場動態，需要從細分市場的觀點出發，將設計和商業化與具體的應用情境和採購管道連結起來。依最終用戶分類，診所、居家醫療機構和醫院系統的採用模式各不相同，而醫院的需求又會根據規模小規模進一步細分。大型醫院通常優先考慮整合安全功能和批量採購管道，而小規模醫院則傾向於尋求經濟高效且易於實施的解決方案。產品類型分為傳統型和安全工程型。由於規避風險的臨床通訊協定和針刺預防事故計畫的推行，安全設備正日益受到關注。

從區域觀點，分析美洲、歐洲、中東和非洲以及亞太市場的採用促進因素、監管差異和分銷模式。

區域趨勢對競爭優勢、供應商策略和實施時間表有顯著影響，應體現在市場進入和擴張計畫中。在美洲，完善的採購流程和一體化的醫院系統為能夠提供強力的臨床證據、一體化供應方案和可靠物流的供應商創造了機會。區域分銷網路和聯合採購模式往往會促使供應商期望簽​​訂長期合約並附加價值服務。在歐洲、中東和非洲地區，監管環境的多樣性以及集中式和分散式採購模式的混合，要求供應商採取適應性強的合規策略和靈活的商業性策略，尤其是在各國衛生機構制定各自的兼容性和滅菌標準的情況下。

深入了解領先製造商與創新新參與企業在管瓶適配器領域的競爭定位、夥伴關係模式和營運能力的差異

管瓶適配器領域的競爭格局由成熟的醫療設備製造商、專業組件供應商以及專注於安全性和自動化的創新新興參與企業組成。市場領導通常透過整合的品質系統、廣泛的監管覆蓋以及可靠的物流和上市後監測能力來支持大型機構契約，從而脫穎而出。新興企業則以敏捷性取勝，它們通常會推出模組化或數位化解決方案，以快速回應臨床回饋和特定應用場景。

為製造商和供應商提供切實可行的策略建議，以加強通路合作，從而提升安全性、增強供應鏈韌性、產生臨床證據並推動產品應用。

產業領導者應優先考慮切實可行的措施，使設計選擇、供應鏈韌性和商業模式與臨床和採購的實際情況相符。首先，在設計生命週期的早期階段就應納入安全性和相容性測試，以減少下游監管方面的阻力，並提升客戶價值提案。其次，應實現關鍵零件供應商多元化，並考慮策略性近岸外包和區域組裝，以縮短前置作業時間，同時降低運輸和關稅相關的風險。

採用透明的多方法調查方法，整合相關人員訪談、監管分析和供應鏈圖譜，以檢驗策略洞察和建議。

本執行摘要的分析是基於多方面的研究方法，整合了主要相關利益者訪談、二手文獻綜述、監管文件分析和供應鏈圖譜。主要研究透過與採購主管、臨床終端使用者、產品開發專業人員和分銷合作夥伴的結構化對話，揭示了實用化障礙、偏好促進因素和服務期望。二級資訊來源包括監管指南、行業最佳實踐文件、技術標準以及近期關於醫療設備安全性、材料相容性和臨床工作流程的同行評審文獻。

總之，我們強調以安全驅動的設計、供應鏈的柔軟性和循證實施為基礎的綜合觀點，作為管瓶適配器相關人員獲得永續競爭優勢的基礎。

總之，管瓶適配器相關人員面臨著日益成長的安全期望、材料和設計創新、採購行為的轉變以及對具有韌性和靈活性的供應鏈的需求等挑戰。那些將產品開發與嚴格的相容性測試相結合、建立多元化籌資策略並設計針對不同終端使用者環境量身定做的通路模式的公司，將更有利於獲得機構和臨床的持續認可。此外，與負責人積極合作檢驗加大對實證醫學的投入，將有助於加速產品融入診斷和治療流程。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依最終用戶管瓶轉接器市場

  • 診所
  • 居家照護
  • 醫院

第9章 依給藥方式管瓶轉接器市場

  • 自動的
  • 手動的

第10章 按分銷管道分類的管瓶適配器市場

  • 離線
  • 線上

第11章 依材料管瓶轉接器市場

  • 金屬
  • 塑膠

第12章管瓶適配器市場按應用領域分類

  • 診斷
    • 血液檢查
    • 疫苗接種
  • 治療
    • 藥物輸送
    • 免疫療法

第13章 區域性管瓶轉接器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章管瓶轉接器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國管瓶轉接器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國管瓶轉接器市場

第17章：中國管瓶適配器市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies Inc.
  • Amsino International Inc.
  • ARaymond
  • B. Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Company（BD）
  • Cardinal Health, Inc.
  • Corvida Medical
  • Dedecke GmbH
  • EQUASHIELD LLC
  • Gerresheimer
  • Helapet Limited
  • ICU Medical
  • MedXL Inc.
  • Miltenyi Biotec BV & Co. KG
  • Nipro Corporation
  • Simplivia Healthcare Ltd.
  • Stevanato Group SpA
  • Union Plastic SAS
  • West Pharmaceutical Services, Inc.
Product Code: MRR-4F7A6D4FB92F

The Vial Adapter Market was valued at USD 805.17 million in 2025 and is projected to grow to USD 829.60 million in 2026, with a CAGR of 6.91%, reaching USD 1,285.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 805.17 million
Estimated Year [2026] USD 829.60 million
Forecast Year [2032] USD 1,285.47 million
CAGR (%) 6.91%

A concise strategic introduction that frames vial adapter design, clinical utility, and procurement priorities to inform executive decision-making and product strategy

Vial adapters are an essential interface between pharmaceutical products and delivery systems, enabling safe, efficient access to vial contents across clinical and non-clinical settings. This executive summary synthesizes strategic insights about the competitive environment, technology evolution, regulatory interactions, and supply chain dynamics that will influence procurement, design decisions, and commercialization strategies for stakeholders across the value chain. It is intended for senior executives, product strategists, procurement leaders, and clinical operations teams seeking to align investments with practical adoption pathways.

Beginning with an overview of current technology trends and procurement drivers, the narrative traces how safety priorities, materials selection, and channel dynamics interact with clinical applications such as diagnostic sampling and therapeutic delivery. The summary then transitions to an analysis of structural disruptions, including trade policy influences and downstream distribution shifts, before concluding with pragmatic recommendations and methodological notes. Throughout, the emphasis remains on actionable insights that translate technical and regulatory complexity into clear implications for product development, sourcing, and market engagement.

A detailed examination of converging technological, regulatory, and procurement shifts that are redefining product expectations and supply chain priorities for vial adapters

The landscape for vial adapters is undergoing multiple simultaneous shifts that are reshaping product road maps and commercial approaches. Technological maturation is visible in the spread of safety-engineered designs and automated delivery interfaces, which are increasingly expected in higher acuity environments. Concurrently, material science advances enable lighter, more ergonomically friendly components that reduce device-related waste and improve handling in both point-of-care and home settings.

Regulatory emphasis on safe needleless access and compatibility testing is altering the cadence of product approvals and post-market surveillance obligations, thereby elevating quality systems and evidence generation as competitive differentiators. In procurement, buyers are placing greater weight on total cost of ownership, device lifecycle management, and supplier resilience. Finally, digital integration-ranging from track-and-trace identifiers to compatibility databases-has grown from a nice-to-have to a key enabler of inventory control and clinical compliance. Taken together, these transformative shifts favor manufacturers and distributors who can demonstrate safety, interoperability, and supply stability while supporting diverse channels and end-user environments.

An analytical perspective on how evolving tariff dynamics have shifted sourcing strategies, manufacturing footprints, and distribution resilience for vial adapter stakeholders

Recent trade measures and tariff dynamics originating from large importing economies have had a broad influence on the supply chains that feed vial adapter production and distribution. Tariff adjustments have amplified the importance of supply chain diversification, prompting many organizations to reassess component sourcing, manufacturing footprints, and inventory strategies to mitigate exposure to cross-border cost volatility. In response, procurement teams have accelerated supplier qualification activities and prioritized multi-sourcing to preserve continuity of supply.

Moreover, tariff-driven cost pressures have encouraged manufacturers to pursue design efficiencies and material substitutions where clinically permissible, while remaining attentive to regulatory compatibility and product performance. This in turn has spurred nearshoring conversations and selective relocation of assembly operations closer to major demand centers to reduce transit-dependent risk. At the same time, distributors and channel partners have adapted commercial terms and stocking practices to absorb short-term price impacts while maintaining predictable service levels for hospitals, clinics, and home care providers. Overall, the cumulative effect of tariff fluctuations has been to raise the strategic value of supply chain visibility, flexible manufacturing, and contractual agility across the ecosystem.

A comprehensive segmentation-driven analysis linking end-user settings, product types, delivery modes, channel structures, material choices, and clinical applications to strategic product positioning

Understanding market dynamics requires a segmentation-aware perspective that ties design and commercialization to specific use contexts and procurement pathways. By end user, adoption patterns differ between clinic environments, home care settings, and hospital systems, with hospital demand further split by the needs of large hospitals versus small hospitals; large hospitals typically prioritize integrated safety features and bulk procurement pathways while small hospitals often seek cost-effective, easy-to-deploy solutions. Product type divides offerings into conventional designs and safety-engineered variants, where safety devices command attention from risk-averse clinical protocols and programs focused on needlestick prevention.

Delivery mode influences operational fit, as automatic delivery interfaces are preferred when repeatability and reduced manual handling are critical, whereas manual devices retain appeal where simplicity and low maintenance are paramount. Channel considerations-direct sales relationships, distributor networks, and online platforms-shape commercial strategy by defining margins, reach, and post-sale support expectations. Material choices between metal and plastic affect durability, sterilization compatibility, and per-unit cost considerations, with each material class presenting distinct manufacturing and regulatory implications. Finally, application segmentation into diagnostic and therapeutic uses reveals different evidence and compatibility requirements; diagnostic workstreams include blood testing and vaccine administration where sample integrity and rapid handling matter, while therapeutic applications encompass drug delivery and immunotherapy where dosage precision, biocompatibility, and connector integrity are paramount. Integrating these segmentation lenses highlights where innovation investments, regulatory planning, and channel development are most likely to yield differentiated returns.

A regionally nuanced perspective on adoption drivers, regulatory variance, and distribution models across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence competitive advantage, supplier strategies, and adoption timelines, and should therefore inform market entry and expansion plans. In the Americas, procurement sophistication and consolidated hospital systems create opportunities for vendors who can demonstrate robust clinical evidence, integrated supply programs, and reliable logistics; regional distribution networks and group purchasing models often drive long-term contracts and expectations for value-added services. In Europe, Middle East & Africa, regulatory heterogeneity and a mix of centralized and decentralized procurement models require adaptive compliance strategies and flexible commercial approaches, particularly where national health authorities impose distinct compatibility or sterilization standards.

In the Asia-Pacific region, a combination of large manufacturing capabilities and rapidly growing home care adoption present unique opportunities for scale and cost leadership, while rising standards of clinical hygiene are increasing demand for safety-engineered products. Across all regions, differences in reimbursement mechanisms, contract structures, and clinical practice norms dictate tailored engagement models, and successful players will align product specifications, distribution partnerships, and service offerings to regional procurement rhythms and regulatory expectations.

Insights into competitive positioning, partnership models, and the operational capabilities that distinguish leading manufacturers and innovative entrants in the vial adapter arena

Competitive dynamics in the vial adapter space are shaped by a mix of established medical device manufacturers, specialist component producers, and innovative newcomers focused on safety and automation. Market leaders tend to differentiate through integrated quality systems, broad regulatory footprints, and the ability to support large institutional contracts with dependable logistics and post-market surveillance capabilities. Emerging firms often compete on nimbleness, introducing modular or digitally enabled solutions that respond quickly to clinical feedback and niche use cases.

Partnerships between device manufacturers and logistics or contract manufacturing organizations are increasingly common, as they allow firms to scale production rapidly while preserving quality control. Strategic collaborations with clinical networks and independent validation bodies also help to accelerate acceptance in hospital systems and clinics. From a competitive standpoint, success favors those who can demonstrate consistent compliance documentation, responsive customer support, and a clear roadmap for product evolution that aligns with clinical safety priorities and evolving delivery modalities.

Actionable strategic recommendations for manufacturers and suppliers to strengthen safety, supply resilience, clinical evidence generation, and channel alignment to drive adoption

Industry leaders should prioritize a set of pragmatic actions that align design choices, supply resilience, and commercial models with clinical and procurement realities. First, embed safety and compatibility testing early in the design lifecycle to reduce downstream regulatory friction and to strengthen customer value propositions. Second, diversify supplier bases for critical components and consider strategic nearshoring or regional assembly to mitigate transit and tariff-related exposure while shortening lead times.

Third, align channel strategies to customer preferences by balancing direct engagement for large institutional buyers with distributor and online models that serve clinics and home care markets efficiently. Fourth, invest in evidence generation and clinician engagement to demonstrate device performance across diagnostic and therapeutic applications, thereby smoothing adoption in both blood testing, vaccine administration, drug delivery, and immunotherapy workflows. Finally, build flexible commercial terms and service layers-such as training, compatibility support, and inventory management-to differentiate offerings and deepen customer relationships. Collectively, these actions will enhance resilience, accelerate adoption, and protect margins amid shifting external pressures.

A transparent multi-method research methodology integrating stakeholder interviews, regulatory analysis, and supply chain mapping to validate strategic insights and recommendations

The analysis underpinning this executive summary draws on a multi-method research approach that integrates primary stakeholder interviews, secondary literature review, regulatory filing analysis, and supply chain mapping. Primary engagements included structured conversations with procurement leaders, clinical end users, product development specialists, and distribution partners to surface practical adoption barriers, preference drivers, and service expectations. Secondary sources comprised regulatory guidance, industry best-practice documents, technical standards, and recent peer-reviewed literature addressing device safety, materials compatibility, and clinical workflows.

Complementing qualitative inputs, the methodology incorporated comparative analyses of manufacturing footprints and logistics pathways to identify points of supply fragility and potential efficiencies. Triangulation across these inputs ensured that thematic conclusions reflect both frontline practitioner experience and documented regulatory or technical constraints. Throughout the research, attention was given to methodological rigor: interview protocols were standardized, source provenance was tracked, and findings were iteratively validated with subject-matter experts to minimize bias and enhance reliability.

A conclusive synthesis emphasizing safety-led design, supply chain flexibility, and evidence-driven adoption as the pillars of durable competitive advantage for vial adapter stakeholders

In sum, vial adapter stakeholders face a landscape defined by rising safety expectations, material and design innovation, evolving procurement behavior, and the need for resilient, flexible supply chains. Those who align product development with rigorous compatibility testing, build diversified sourcing strategies, and tailor channel models to distinct end-user environments will be best positioned to capture sustained institutional and point-of-care adoption. Moreover, proactive engagement with clinical validators and investment in evidence generation will expedite integration into diagnostic and therapeutic workflows.

Looking ahead, maintaining agility in response to trade and regulatory shifts will be a critical determinant of operational continuity and competitive advantage. By translating the insights presented in this summary into targeted product enhancements, strategic supplier partnerships, and regionally calibrated go-to-market plans, organizations can strengthen their market positioning and support safer, more reliable access to injectable therapies and diagnostic procedures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vial Adapter Market, by End User

  • 8.1. Clinic
  • 8.2. Home Care
  • 8.3. Hospital

9. Vial Adapter Market, by Delivery Mode

  • 9.1. Automatic
  • 9.2. Manual

10. Vial Adapter Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Vial Adapter Market, by Material

  • 11.1. Metal
  • 11.2. Plastic

12. Vial Adapter Market, by Application

  • 12.1. Diagnostic
    • 12.1.1. Blood Testing
    • 12.1.2. Vaccine Administration
  • 12.2. Therapeutic
    • 12.2.1. Drug Delivery
    • 12.2.2. Immunotherapy

13. Vial Adapter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Vial Adapter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Vial Adapter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Vial Adapter Market

17. China Vial Adapter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies Inc.
  • 18.6. Amsino International Inc.
  • 18.7. ARaymond
  • 18.8. B. Braun SE
  • 18.9. Baxter International Inc.
  • 18.10. Becton Dickinson and Company (BD)
  • 18.11. Cardinal Health, Inc.
  • 18.12. Corvida Medical
  • 18.13. Dedecke GmbH
  • 18.14. EQUASHIELD LLC
  • 18.15. Gerresheimer
  • 18.16. Helapet Limited
  • 18.17. ICU Medical
  • 18.18. MedXL Inc.
  • 18.19. Miltenyi Biotec B.V. & Co. KG
  • 18.20. Nipro Corporation
  • 18.21. Simplivia Healthcare Ltd.
  • 18.22. Stevanato Group S.p.A.
  • 18.23. Union Plastic S.A.S.
  • 18.24. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VIAL ADAPTER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VIAL ADAPTER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VIAL ADAPTER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VIAL ADAPTER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VIAL ADAPTER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VIAL ADAPTER MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VIAL ADAPTER MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VIAL ADAPTER MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VIAL ADAPTER MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIAL ADAPTER MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIAL ADAPTER MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIAL ADAPTER MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VIAL ADAPTER MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VIAL ADAPTER MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VIAL ADAPTER MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VIAL ADAPTER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIAL ADAPTER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VIAL ADAPTER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VIAL ADAPTER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VIAL ADAPTER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VIAL ADAPTER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VIAL ADAPTER MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VIAL ADAPTER MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VIAL ADAPTER MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VIAL ADAPTER MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VIAL ADAPTER MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VIAL ADAPTER MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VIAL ADAPTER MARKET SIZE, BY BLOOD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VIAL ADAPTER MARKET SIZE, BY BLOOD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VIAL ADAPTER MARKET SIZE, BY BLOOD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VIAL ADAPTER MARKET SIZE, BY VACCINE ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VIAL ADAPTER MARKET SIZE, BY VACCINE ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VIAL ADAPTER MARKET SIZE, BY VACCINE ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VIAL ADAPTER MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VIAL ADAPTER MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VIAL ADAPTER MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VIAL ADAPTER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VIAL ADAPTER MARKET SIZE, BY IMMUNOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VIAL ADAPTER MARKET SIZE, BY IMMUNOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VIAL ADAPTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS VIAL ADAPTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VIAL ADAPTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 128. GCC VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GCC VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GCC VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 135. GCC VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 152. G7 VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. G7 VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. G7 VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 159. G7 VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 160. NATO VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. NATO VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NATO VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. NATO VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NATO VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 167. NATO VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL VIAL ADAPTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA VIAL ADAPTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA VIAL ADAPTER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA VIAL ADAPTER MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA VIAL ADAPTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA VIAL ADAPTER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA VIAL ADAPTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA VIAL ADAPTER MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA VIAL ADAPTER MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)